Risk factor
Very high price volatility
Profitability factor
Strong margins and returns
In Guru Portfolios
Portfolio Weight (%)
Change
Fund
Portfolio Weight (%)
Change
Fund
Portfolio Weight (%)
Change
Fund
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
About
Lifeway Foods, Inc. manufactures and distributes a variety of probiotic-rich goods, serving both the United States and international markets. Its principal offering is drinkable kefir, a fermented dairy item available in numerous forms, including organic and conventional options, various volumes, flavors, and formulations such as reduced-fat, fat-free, whole milk, high-protein, and BioKefir. Additionally, the company supplies European-style soft cheeses, cream, and other dairy selections. Their product portfolio also features ProBugs, a dedicated kefir line for children; single-serving cupped kefirs; Icelandic Skyr, which includes strained kefir and yogurt products; and frozen kefir in both soft-serve and pre-packaged pint formats. These products are sold under their proprietary Lifeway and Fresh Made brand names, and also as private label merchandise for other customers. Sales are primarily conducted via their internal sales personnel, alongside the use of brokers and third-party distributors. The company was founded in 1986 and maintains its headquarters in Morton Grove, Illinois.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA
Target Price
The average target price of LWAY is 34.5 and suggests 9.68% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio